| Investigator | Title | Sponsor | ID | Dates | Amount | 
        
            | Maisam Abu-El-Haija, MD | Predicting Severity and Improving the Outcomes of Pediatric Pancreatitis | National Institutes of Health (NIH) | K23DK118190 | 7/17/2018 - 5/31/2020 | $379,188 | 
        
            | Maisam Abu-El-Haija, MD | INSPPIRE To Study Pancreatitis in Children | University of Iowa (National Institutes of Health (NIH)) | W001038585 | 9/1/2017 - 8/31/2019 | $31,800 | 
        
            | Akihiro Asai, MD-PHD | Modeling patient-specific genetic cholestasis with induced human hepatocytes | Amer Assoc for the Study of Liver Dis | AASLD- 2018 AASLD | 7/1/2018 - 6/30/2019 | $100,000 | 
        
            | Jorge A Bezerra, MD | Clinical Center for Cholestatic Liver Disease in Children | National Institutes of Health (NIH) | U01DK062497 | 6/1/2018 - 5/31/2020 | $633,496 | 
        
            | Jorge A Bezerra, MD | Biological Basis of Phenotypes and Clinical Outcomes in Biliary Atresia | National Institutes of Health (NIH) | R01DK083781 | 9/1/2018 - 8/31/2019 | $375,500 | 
        
            | Jorge A Bezerra, MD | Digestive Health Center: Bench to Bedside Research in Pediatric Digestive Disease | National Institutes of Health (NIH) | P30DK078392 | 6/1/2018 - 5/31/2019 | $1,161,891 | 
        
            | Jorge A Bezerra, MD | Childhood Liver Disease Research Network Data Coordinating Center | Arbor Research Collaborative for Health (National Institutes of Health (NIH)) | FORCE U01DK062456 | 6/1/2018 - 5/31/2019 | $4,159 | 
        
            | Jorge A Bezerra, MD | Immunologic Dysfunction in Biliary Atresia | National Institutes of Health (NIH) | R01DK064008 | 2/1/2019 - 1/31/2020 | $446,970 | 
        
            | Clifford Chin, MD | Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children | Stanford University (National Institutes of Health (NIH)) | 60837668-107582 (U01 | 2/1/2018 - 1/31/2019 | $23,850 | 
        
            | Lee A Denson, MD | Causes and consequences of neutrophil dysfunction in early onset Crohn's disease | Emory University (National Institutes of Health (NIH)) | T660056 | 8/1/2017 - 7/31/2019 | $353,201 | 
        
            | Lee A Denson, MD | Pediatric Gastroenterology and Nutrition Training Grant | National Institutes of Health (NIH) | T32DK007727 | 7/1/2018 - 6/30/2019 | $372,563 | 
        
            | Lee A Denson, MD | Study of Environmental Enteropathy and Malnutrition in Pakistan (Seem Pakistan) | University of Virginia (Bill & Melinda Gates Foundation) | UVA_Denson | 7/1/2016 - 12/31/2019 | $1,938,384 | 
        
            | Lee A Denson, MD | Dosing and Pilot Efficacy of 2'-Fucosyllactose in Inflammatory Bowel Disease | National Institutes of Health (NIH) | R01HD094862 | 7/12/2018 - 3/31/2020 | $1,152,609 | 
        
            | Lee A Denson, MD | RISK Stratification in Pediatric IBD | Emory University (Crohn's & Colitis Foundation of America) | A036261 | 1/1/2018 - 12/31/2018 | $105,419 | 
        
            | Xiaonan Han, PHD | Regulation of Adult Intestinal Stem Cell Response to Enteric Infection and Inflammation in Pediatric Ileal Crohn’s Diseases | Crohn's & Colitis Foundation of America | CCFA -Han | 7/1/2018 - 6/30/2019 | $115,830 | 
        
            | James E Heubi, MD | Sterol and Isoprenoid Diseases Rare Diseases Consortium | University of Nebraska Medical Center (National Institutes of Health (NIH)) | 34-5321-2003-010 | 9/1/2017 - 8/31/2018 | $8,306 | 
        
            | Stacey Huppert, PHD | Building a functional biliary system from hepatocytes | National Institutes of Health (NIH) | R01DK107553 | 8/1/2018 - 7/31/2019 | $477,173 | 
        
            | Stacey Huppert, PHD | Alagille Syndrome Scientific Meeting – Connecting the Pieces | National Institutes of Health (NIH) | R13DK120294 | 3/1/2019 - 2/28/2020 | $10,000 | 
        
            | Sudhir Kumar, PHD | Mechanisms of liver failure | National Institutes of Health (NIH) | IPA_Kumar | 10/5/2018 - 10/4/2019 | $65,806 | 
        
            | Alexander Miethke, MD | A Multi-Center Group to Study Acute Liver Failure in Children | University of Pittsburgh (National Institutes of Health (NIH)) | 0019927 (124826-11) | 9/1/2017 - 8/31/2018 | $10,000 | 
        
            | Alexander Miethke, MD | The evaluation of the iBAT inhibitor | University of Michigan (National Institutes of Health (NIH)) | U01 DK062456 | 6/1/2018 - 5/31/2019 | $60,698 | 
        
            | Alexander Miethke, MD | Pediatric PSC Partners- Utah | University of Utah (PSC Partners Seeking a Cure) | 10045904-CINC-03 | 7/1/2018 - 6/30/2019 | $4,000 | 
        
            | Alexander Miethke, MD | Dissecting the pathogenesis and outcomes of PSC using multi-omics by studying the exosome and genome | Mayo Clinic (National Institutes of Health (NIH)) | CIN-245818 | 9/1/2018 - 7/31/2019 | $25,000 | 
        
            | Phillip P. Minar, MD | Pharmacokinetic Evaluation to Optimize lnfliximab Monotherapy with Personalized Pharmacodynamic Biomarkers | National Institutes of Health (NIH) | R03DK118314 | 9/1/2018 - 8/31/2019 | $119,250 | 
        
            | Phillip P. Minar, MD | Precision Crohn’s Disease Management Utilizing Predictive Protein Panels | The Leona M & Harry B Helmsley Charitabl | 1911-03345 | 3/1/2019 - 2/29/2020 | $783,343 | 
        
            | Phillip P. Minar, MD | Pharmacodynamic Targets to Enrich a Personalized Infliximab Dosing Dashboard | Crohn's & Colitis Foundation of America | 614971 | 1/1/2019 - 12/31/2019 | $110,000 | 
        
            | Joseph Palermo, MD-PHD | Longitudinal Study of Cystic Fibrosis Liver Disease | The Children's Hospital of Denver (Cystic Fibrosis Fdn Therapeutics, Inc) | NARKEW07AO | 1/1/2018 - 12/31/2018 | $120,714 | 
        
            | Joseph Palermo, MD-PHD | Longitudinal Study of Cystic Fibrosis Liver Disease | The Children's Hospital of Denver (Cystic Fibrosis Fdn Therapeutics, Inc) | TCHG07083 | 1/1/2015 - 12/31/2018 | $14,969 | 
        
            | Richa Rani, PHD | Mechanisms of Liver Failure | National Institutes of Health (NIH) | IPA Rani | 1/3/2018 - 1/2/2020 | $119,429 | 
        
            | Michael Rosen, MD-MS | Type 2 cytokines and innate lymphoid cells in pediatric ulcerative colitis | National Institutes of Health (NIH) | R01DK117119 | 7/18/2018 - 5/31/2019 | $528,098 | 
        
            | Takanori Takebe, MD | Validation of the iPS-derived human liver organoid system as the suitable human non-alcoholic steatohepatitis (NASH) in vitro system to enter into the collaboration regarding CHMC’s NASH organoid model | EA Pharma Co., LTD | SRA181101 | 3/1/2019 - 2/29/2020 | $122,487 | 
        
            | Kelli L VanDussen, PHD | Defining the Basis of Epithelial Defects in Crohn's Disease Patients | National Institutes of Health (NIH) | K01DK109081 | 2/1/2019 - 1/31/2020 | $293,766 | 
        
            | Stavra A Xanthakos, MD | Outcome of NASH in Adolescents after Bariatric Surgery vs. Lifestyle Intervention | National Institutes of Health (NIH) | R01DK100429 | 7/1/2018 - 6/30/2019 | $556,845 | 
        
            | Stavra A Xanthakos, MD | Clinical Research Network in NASH | Cleveland Clin Lerner Col of Med of CWRU (National Institutes of Health (NIH)) | No U01DK061732 | 7/1/2018 - 6/30/2019 | $227,431 | 
        
            | Stavra A Xanthakos, MD | Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network | Johns Hopkins University (National Institutes of Health (NIH)) | 2003984228 | 7/1/2018 - 6/30/2019 | $20,337 | 
        
            | Chunyue Yin, PHD | Molecular genetics of progressive familial intrahepatic cholestasis | AGA Fdn for Digestive Health &Nutrition | 2018 AGA-Elsevier Pi | 7/1/2018 - 6/30/2019 | $25,000 | 
        
            | Chunyue Yin, PHD | Molecular targets in cholestasis caused by bile salt export pump deficiency | National Institutes of Health (NIH) | R01DK117266 | 9/20/2018 - 7/31/2019 | $375,722 | 
        
            | Current Year Direct | $11,273,234 |